Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea
NCT ID: NCT01672606
Last Updated: 2016-02-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2012-05-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phamacological Reversal of Airway Instability During Sedation
NCT01171118
Pharmacological Activation of HMN for OSA
NCT03640052
Effect of Interscalene Block on Obstructive Sleep Apnea in Shoulder Surgery Patients
NCT02034370
The Effects of Nasal Airflow on Upper Airway Dilator Muscles During Sleep
NCT03506178
Sleep Apnea: Mechanism and Cerebrovascular Consequences
NCT00108602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rocuronium
Intravenous infusion of rocuronium with the goal of TOF 0.70 and \>0.90
Rocuronium
Partial neuromuscular blockade with rocuronium with a TOF 0.70
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rocuronium
Partial neuromuscular blockade with rocuronium with a TOF 0.70
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
70 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Malin Jonsson Fagerlund
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Malin Jonsson Fagerlund
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malin Jonsson Fagerlund, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska University Hospital and Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology, Surgical Sciences and Intensive Care Medicine, Karolinska University Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OSA ROC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.